Related Experiment Videos
Bone biomarkers as tools in osteoporosis management
1Department of Orthopaedics, University of Washington, Seattle, USA.
Spine
|February 7, 1998
Summary
Biochemical markers can assess bone turnover for osteoporosis management. Specific markers for bone formation and resorption aid in predicting fracture risk and monitoring treatment effectiveness.
Area of Science:
- Biochemistry
- Orthopedics
- Endocrinology
Background:
- Osteoporosis management increasingly utilizes biochemical tests to index bone turnover.
- Bone turnover markers provide complementary information to bone mass measurements for fracture risk assessment.
Purpose of the Study:
- To review bone formation and resorption markers.
- To discuss their molecular basis, clinical performance, and future potential.
- To highlight their role in osteoporosis management and therapy monitoring.
Main Methods:
- Review of existing literature on biochemical markers of bone turnover.
- Analysis of molecular basis, clinical utility, and responsiveness of various markers.
- Comparison of bone formation markers (bone-specific alkaline phosphatase, osteocalcin) and resorption markers (collagen degradation products, telopeptides).
Main Results:
- Bone-specific alkaline phosphatase and osteocalcin are key markers for bone formation.
- Urine collagen degradation products, especially cross-linked telopeptides (NTx and CTx), are highly specific for bone resorption.
- Telopeptide markers (NTx and CTx) demonstrate high specificity and responsiveness to systemic osteoclast activity.
Conclusions:
- Biochemical markers complement bone mass measurements in predicting fracture risk.
- Specific resorption markers are valuable for monitoring antiresorptive therapy effectiveness.
- Telopeptide markers (NTx and CTx) are the most specific and responsive indicators of bone resorption.